The Scientist

» NSF and immunology

Most Recent

image: Drug Allergy in the Pocket

Drug Allergy in the Pocket

By | October 1, 2012

An HIV drug can bind to and alter the function of an immune molecule, causing a dangerous reaction in patients with a particular allele.

0 Comments

image: 2012 Labbies Honorable Mentions

2012 Labbies Honorable Mentions

By | October 1, 2012

Check out other memorable images and videos that were submitted to this year’s Labby Multimedia Awards.

0 Comments

image: US Voters Oppose Science Cuts

US Voters Oppose Science Cuts

By | September 24, 2012

Many Americans who are likely to vote in upcoming elections are not in favor of across-the-board cuts to non-discretionary funding.

3 Comments

image: Sequestration Threatens Science

Sequestration Threatens Science

By | September 19, 2012

If Congress can't reach an agreement on reducing the federal deficit by $1.2 trillion, automatic decreases to key federal science agency budgets go into effect.

7 Comments

image: Dotting “i”s and Crossing “t”s

Dotting “i”s and Crossing “t”s

By | September 17, 2012

As federal budgets tighten, the US government is getting serious about enforcing reporting and administrative rules that accompany academic grants.

2 Comments

image: The NSF Shake-Up

The NSF Shake-Up

By | September 7, 2012

The federal agency is shuffling around its programs to streamline management and promote international scientific collaboration.

2 Comments

image: A Funding Reboot

A Funding Reboot

By | September 5, 2012

Scientists ask the NSF to reconsider a granting mechanism they say could hurt junior faculty.

0 Comments

image: A Good Night’s Sleep

A Good Night’s Sleep

By | September 1, 2012

Sleep-wake cycles affect how well our bodies fight disease.

0 Comments

image: The Danger of Vaccine Exemptions

The Danger of Vaccine Exemptions

By | August 30, 2012

Are states with less rigorous rules about which children can claim an exception from vaccination in kindergarten putting communities at higher risk of childhood disease?

4 Comments

image: Clinical Trial Misfortune

Clinical Trial Misfortune

By | August 28, 2012

A human trial of a hepatitis C treatment is shut down after one of the participants died.

1 Comment

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Sequencing Reveals Genomic Diversity of the Human Brain
  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech